See up to 3 months of EXOZ. The 7-day demo opens the 1M and 3M ranges and puts EXOZ on your watchlist.
Start 7-day demoLatest EXOZ insider trades
About EXOZYMES INC. (EXOZ)
EXOZYMES INC. files with the SEC under CIK 0002010788 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
EXOZ Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 5 | 855 | $6K |
| Grant or award | 2 | 53,841 | |
| Option exercise | 4 | 105,152 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
EXOZ insider transactions (Form 4)
2113 Form 4 filings on record, the earliest from Nov 18, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Fouad Nawaz - Officer | Grant or award | Stock Option (right to buy) | 45,000 | $0.00 | - | |
| Michael Heltzen - Officer | Open-market purchase | Common Stock | 4 | $7.58 | $30 | |
| Michael Heltzen - Officer | Open-market purchase | Common Stock | 251 | $7.35 | $2K | |
| Michael Heltzen - Officer | Open-market purchase | Common Stock | 250 | $7.60 | $2K | |
| Michael Heltzen - Officer | Open-market purchase | Common Stock | 250 | $7.52 | $2K | |
| Michael Heltzen - Officer | Open-market purchase | Common Stock | 100 | $7.50 | $750 | |
| Michael Heltzen - Officer | Grant or award | Common Stock | 8,841 | $6.40 | $57K | |
 Damien Alan Perriman - Officer | Option exercise | Common Stock | 19,612 | - footnote F1 | - | |
| Damien Alan Perriman - Officer | Option exercise | Restricted Stock Unit | 19,612 | $0.00 | - | |
| ||||||
 Tyler Paz Korman - Officer | Option exercise | Common Stock | 32,964 | - footnote F1 | - | |
| Tyler Paz Korman - Officer | Option exercise | Restricted Stock Unit | 32,964 | $0.00 | - | |
| ||||||
| Tyler Paz Korman - Officer | Open-market sale | COMMON STOCK | 750 | $10.04 | $8K | |
| Tyler Paz Korman - Officer | Open-market sale | COMMON STOCK | 750 | $10.53 | $8K | |
| Damien Alan Perriman - Officer | Grant or award | COMMON STOCK | 8,887 | $8.44 | $75K | |
| Paul Hideo Opgenorth - Officer | Grant or award | COMMON STOCK | 3,999 | $8.44 | $34K | |
| Fouad Nawaz - Officer | Grant or award | COMMON STOCK | 5,999 | $8.44 | $51K | |
| Tyler Paz Korman - Officer | Grant or award | COMMON STOCK | 5,332 | $8.44 | $45K | |
| Michael Heltzen - Officer | Open-market purchase | Common Stock | 1,040 | $10.22 | $11K | |
| Michael Heltzen - Officer | Open-market purchase | Common Stock | 1,984 | $11.10 | $22K | |
| Paul Hideo Opgenorth - Officer | Other | Common Stock | 2,344 | $6.40 | $15K | |
| MDB Capital Holdings, LLC - 10% Owner | Other | Common Stock | 122,657 | $6.40 | $785K | |
EXOZ insider trading FAQ
What is the latest insider trade for EXOZ?
EXOZYMES INC. (EXOZ) had 4 insider filings in the last 90 days, with the most recent on 2026-09-17. The full record for EXOZ runs to 13 Form 4 filings, the earliest from 2024-11-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying EXOZ stock?
5 insider purchases of EXOZ were filed in the last 90 days, totaling $6K.
How many insiders are selling EXOZ stock?
No insider sales of EXOZ were filed in the last 90 days. 2 sales are on record for this company.
Where can I see EXOZ SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects EXOZ Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Fouad Nawaz view on EDGAR
- - Michael Heltzen view on EDGAR
- - Damien Alan Perriman view on EDGAR
- - Tyler Paz Korman view on EDGAR
- - Tyler Paz Korman view on EDGAR
- - Damien Alan Perriman view on EDGAR
- - Paul Hideo Opgenorth view on EDGAR
- - Fouad Nawaz view on EDGAR
- - Tyler Paz Korman view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where EXOZ's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow EXOZ with a 7-day demo
- EXOZ on your watchlist
- Every EXOZ Form 4 filing on record
- Up to 3 months of EXOZ price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
